Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,127,596
-
Total 13F shares
-
4,630,694
-
Share change
-
+953,028
-
Total reported value
-
$247,055
-
Put/Call ratio
-
48%
-
Price per share
-
$0.05
-
Number of holders
-
21
-
Value change
-
-$42,442
-
Number of buys
-
12
-
Number of sells
-
10
Institutional Holders of Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA) as of Q1 2025
As of 31 Mar 2025,
Ocean Biomedical, Inc. - Common Stock, $0.0001 par value (OCEA) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,630,694 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, Vanguard Personalized Indexing Management, LLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Revolve Wealth Partners, LLC, BlackRock, Inc., and STATE STREET CORP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.